The authors indicated that prospective clinical trials investigating DTIC-based systemic chemotherapies and liver-directed treatments are necessary to validate their findings.
ASCO named the advance in their annual report, Clinical Cancer Advances: ASCO’s Annual Report on Progress Against Cancer, highlighting novel advances and listing research priorities for the cancer community.
Inconsistencies observed by researchers on these websites indicated that efforts are needed to improve website content and readability.
Delivering the PDA to clients of tobacco quit lines, researchers highlighted the importance of broader dissemination and greater effect of the intervention.
Across all oncologic procedures observed in this study, the robotic approach was found to be most associated with lower out-of-pocket costs.
For the first time in 50 years, the government agency is examining asbestos testing for talc powders and cosmetics after traces of the known carcinogen were found in a number of such products.
The expert spoke about the best way for physicians to discuss biomarker testing with their patients to ensure that they have an understanding and can make the right decisions for their treatment.
Treating head and neck cancer with selective neck dissection showed an improvement in shoulder function when level 2b neck dissection was omitted in treatment, according to a recent study.
The expert from Hackensack University Medical Center explained how the complexity of cancer makes it important for physicians to spend time communicating with their patients what their diagnosis entails.
Patients with head and neck cancer saw better overall survival when treated at academic comprehensive cancer programs and integrated network cancer programs, compared to comprehensive community cancer programs and community cancer programs.